Inside Reproductive Health News Digest
Leaders discuss how growth, data-driven care, and new technologies are reshaping outcomes, access, and clinical workflows
Emerging research shows AMH is more than a marker of ovarian reserve, revealing an addressable therapeutic target with applications across menopause, oncofertility, and IVF stimulation.
Heavy communication loads, medication logistics, and schedule volatility are straining clinical teams beyond capacity.
The extraordinary journey of the embryologist whose work you’ll never see—but whose precision could shape your family’s future.
The two private equity firms are infusing some $1.7 billion into the company, which is expected to fuel its continued national expansion.
Meitheal executive Jinsong Liu channels deep regulatory expertise into affordable, high-quality fertility medicines and expanded access to care.
The Heritage Foundation issued a white paper earlier this year urging would-be parents with fertility issues to explore non-IVF options. Clinics and industry observers say it’s not going anywhere.
Outdated imaging and fragmented workflows slow cycle decisions and undermine patient claritY
Clinic networks, compounding specialists, and benefit managers converge on predictable pricing and patient-centered support
Job losses connected to loss in a patent infringement lawsuit last year. Profits up. Reproductive medicine division untouched.
Names Magarelli dean, accelerates recruitment of fertility’s next generation of specialists
Burnout, aging workforce, and hospital contract priorities drive instability across IVF anesthesia coverage
Four fertility nurses across NJ, NC, and SC describe how emotional load, operational complexity, and patient expectations are pushing nurses out.
Menopur loses unique competitive advantage. Consequences to clinics, pharmacies, and other drug makers remain uncertain
IVF Drug markets are small in size and expensive to enter; commitment and collaboration can help drive the momentum needed for new drugs.
Erratic retrievals, constant calls, and outdated workflows drive fatigue—AI scheduling and communication tools offer relief
Younger IVF patients now view digital convenience as standard—clinics must integrate tech without losing the human touch
Infertility left Abby Mercado searching for answers—and connection. Rescripted became the solution for her and so many others.
Erik Strait, MEA Laboratory Manager at Vitrolife, didn't just stumble into fertility science; he unknowingly lived it.
Observer variability and prolonged scan times drive delays in treatment and staff burnout
Biologics drive nearly 40% of drug spending—biosimilars aim to cut costs and expand access
Inconsistent accounting methods drive unpredictable charges as industry grapples with complex cost structures
- CEO and C Suite 1
- Compliance 25
- Fertility Marketing 1
- IVF Lab 4
- International Care 2
- Mergers & Acquisitions 17
- Nursing Management 1
- Partnership & Recruitment 10
- Patient Relations 16
- Physician Leadership 3
- Practice Management 28
- Practice Ownership 1
- Private Equity 7
- Strategy 10
- Technological Innovation 25
- Technology 4
- Training & Education 4
- Venture Capital 5